StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Sucampo Pharmaceuticals Inc

Enter Symbol or Keywords

OPS Ranking for Sucampo Pharmaceuticals Upgraded by StockDiagnostics.com

Stock Quote: (NGM:SCMP)

11/19/2009

6.20

+0.12

+1.97%

37,988

OPS Ranking for Sucampo Pharmaceuticals Upgraded by StockDiagnostics.com

Last

Price Change

% Chg

Volume

Sarasota, FL, November 19, 2009-Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) reported positive OPS (Operational-cashflow Per Share) for its quarter ended September 30, 2009 and StockDiagnostics.com has ... read full story

Website Address:	www.sucampo.com
Industry:	Misc Pharmaceuticals

Most Recent STN Exclusives

11/04/2010

Cash Flow from Operations for SAP AG Reaches Nine Year High

11/04/2010

Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com

11/04/2010

Cash Flow from Operations for Pepco Holdings Reaches Four Year High

11/04/2010

Cash Flow from Operations Increases 151% for KLA-Tencor

11/04/2010

Seven Year High in Cash Flow from Operations for Dana Holding

11/04/2010

Public Service Enterprise's Cash Flow from Operations Increases 48%

11/04/2010

StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"

11/04/2010

Free Cash Flow Turns Negative for Goodyear's Third Quarter

11/04/2010

Cash Flow from Operations for Waste Management Increases 17.7%

11/04/2010

Free Cash Flow for America Movil Reaches Three Year High

Interactive Chart: SCMP

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: SCMP

08/18/2010

Twelve Months EBITDA Turns Positive for Sucampo Pharmaceuticals

08/17/2010

T12-NEWS reports that the Revenue of Sucampo Pharmaceuticals for its 12 month ended June 30, 2010 Decreased by 2.08%

08/16/2010

StockDiagnostics.com Downgrades Sucampo Pharmaceuticals' OPS Ranking

... more SCMP exclusives

Other News Sources: SCMP

02/02/2012

Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD)

12/22/2011

Sucampo Reports Conclusion of Arbitration Hearing

12/08/2011

Sucampo Promotes Birgit Roerig, Ph.D. to Vice President, Pharmacology and Toxicology

... more SCMP news from other sources

Daily Market Updates

02/07/2012

Markets Close Higher with Utilities and Energy as Sector Leaders

U.S. markets ended higher despite the lack of an agreement again today in Greece. A meeting of coalition party leaders in Athens was postponed until tomorrow. Greek Prime Minister Lucas Papademos and the political leaders met again today to try to ag ... read full story